Evidence map›Paper›PMID 12737738›Full record

ArticleEmerging infectious diseases2003

Aeromonas spp. and traveler's diarrhea: clinical features and antimicrobial resistance.

Jordi Vila, Joaquin Ruiz, Francisco Gallardo, Martha Vargas, Lara Soler, Maria José Figueras, Joaquin Gascon

Open access · diamondAbstract read
In one paragraph

Article in Emerging infectious diseases, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 1 synthesis or guideline pooled it, 199 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Detection ofEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  5. Article
  6. Article
  7. Age-Dependent Variations in the Distribution ofPathogens (Basel, Switzerland) · 2025
    Article
  8. Characterization ofChina CDC weekly · 2025
    Article
  9. Review
  10. Chronic Diarrhea Due toPathogens (Basel, Switzerland) · 2023
    Article
  11. Article
  12. Isolation and Identification ofMicroorganisms · 2023
    Article
  13. Virulence · 2022
    Article
  14. Article
  15. Detection of NDM-1-PositiveInfection and drug resistance · 2022
    Article
  16. Article
  17. Fatty Acids-Enriched Fractions ofInternational journal of molecular sciences · 2021
    Article
  18. Article
  19. Travel-Related Antimicrobial Resistance: A Systematic Review.Tropical medicine and infectious disease · 2021
    Review
  20. Frontiers in microbiology · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jordi VilaMicrobiology Laboratory, Institute of Infections and Immunology, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Villaroel 170, 08036 Barcelona, Spain. vila@medicina.ub.es
Joaquin Ruiz
Francisco Gallardo
Martha Vargas
Lara Soler
Maria José Figueras
Joaquin Gascon
Hospital Clínic de Barcelona · ESUniversidad Rovira i Virgili · ESUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traveler's diarrhea is the most common health problem of international travelers. We determined the prevalence of Aeromonas spp. associated with traveler's diarrhea and analyzed the geographic distribution, clinical features, and antimicrobial susceptibility. Aeromonas spp. were isolated as a cause of traveler's diarrhea in 18 (2%) of 863 patients. A. veronii biotype sobria was isolated in nine patients, A. caviae in seven patients, and A. jandaei and A. hydrophila in one patient each. Aeromonas spp. were isolated with a similar prevalence in Africa, Latin America, and Asia. Watery and persistent diarrhea, fever, and abdominal cramps were common complaints. All strains were resistant to ampicillin; showed variable resistance to chloramphenicol, tetracycline, and cotrimoxazole; and were susceptible to cefotaxime, ciprofloxacin, and nalidixic acid. The persistence of symptoms made antimicrobial treatment necessary.

Indexed as

Drug Resistance, BacterialTravelAeromonasAfricaAnti-Bacterial AgentsAsiaDiarrheaGram-Negative Bacterial InfectionsHumansLatin AmericaAnti-Bacterial Agents

Identifiers

PMID12737738
PMCPMC2972757
OpenAlexW2122845671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.